EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TP53 Dysregulation during SARS-CoV-2 Infection: Molecular Mechanisms, Cellular Consequences, and Therapeutic Perspectives

Ali Ayad Abd Al-Hassan, Abdulrahman Salim Qatia Alazzamee, Haneen Ali Darsoon Alshabbani

Medical Science Journal for Advance Research · 30.06.2026 · 7 (2)

DOI: 10.46966/msjar.v7i2.416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Science Journal for Advance Research, online erschienen am 30.06.2026. Verfasst von Ali Ayad Abd Al-Hassan und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Overview of COVID-19 pathogenesis and the central role of TP53 in maintaining genomic stability, DNA repair, apoptosis, immune regulation, and tumor suppression.

Objective

To summarize current evidence regarding the interaction between SARS-CoV-2 infection and the TP53 signaling pathway and discuss potential cellular and clinical consequences.

Methods

A literature search was performed using PubMed, Scopus, Web of Science, and Google Scholar for studies published between 2020 and 2026.

Results

Emerging evidence indicates that SARS-CoV-2 may suppress p53 activity through multiple molecular mechanisms involving MDM2-mediated degradation, modulation of antiviral signaling pathways, and interference with cellular stress responses. Reduced p53 activity may contribute to enhanced viral replication, impaired DNA repair, altered apoptosis, excessive inflammation, and immune dysregulation.

Conclusion

Although current evidence supports transient dysregulation of TP53 signaling during SARS-CoV-2 infection, additional clinical and longitudinal studies are required to determine whether these alterations contribute to long-term pathological consequences, including carcinogenesis.

Zitieren

APA

Al-Hassan, A. A. A., Alazzamee, A. S. Q., & Alshabbani, H. A. D. (2026). TP53 Dysregulation during SARS-CoV-2 Infection: Molecular Mechanisms, Cellular Consequences, and Therapeutic Perspectives. Medical Science Journal for Advance Research, 7(2). https://doi.org/10.46966/msjar.v7i2.416

Vancouver

Al-Hassan AAA, Alazzamee ASQ, Alshabbani HAD. TP53 Dysregulation during SARS-CoV-2 Infection: Molecular Mechanisms, Cellular Consequences, and Therapeutic Perspectives. Medical Science Journal for Advance Research. 2026;7(2). doi:10.46966/msjar.v7i2.416

BibTeX
@article{AlHassan2026,
  author = {Al-Hassan, Ali Ayad Abd and Alazzamee, Abdulrahman Salim Qatia and Alshabbani, Haneen Ali Darsoon},
  title = {TP53 Dysregulation during SARS-CoV-2 Infection: Molecular Mechanisms, Cellular Consequences, and Therapeutic Perspectives},
  journal = {Medical Science Journal for Advance Research},
  year = {2026},
  volume = {7},
  number = {2},
  doi = {10.46966/msjar.v7i2.416}
}
Kostenlos starten →